Literature DB >> 30795003

Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia.

Brandon C McKinney1,2, Matthew L MacDonald1,2, Jason T Newman2, Micah A Shelton2, Rebecca A DeGiosio2,3, Ryan M Kelly4, Kenneth N Fish1,2, Allan R Sampson4, David A Lewis1,2,3, Robert A Sweet5,6,7,8.   

Abstract

Previously, we demonstrated that dendritic spine density (DSD) in deep layer 3 of the primary auditory cortex (A1) is lower, due to having fewer small spines, in subjects with schizophrenia (SZ) than non-psychiatric control (NPC) subjects. We also previously demonstrated that microtubule-associated-protein-2 immunoreactivity (MAP2-IR) in A1 deep layer 3 is lower, and positively correlated with DSD, in SZ subjects. Here, we first sought to confirm these findings in an independent cohort of 25 SZ-NPC subject pairs (cohort 1). We used immunohistochemistry and confocal microscopy to measure DSD and MAP2-IR in A1 deep layer 3. Consistent with previous studies, both DSD and MAP2-IR were lower in SZ subjects. We then tested the hypothesis that MAP2-IR mediates the effect of SZ on DSD in a cohort of 45 SZ-NPC subject pairs (combined cohort) that included all subjects from cohort 1 and two previously studied cohorts. Based on the distribution of MAP2-IR values in NPC subjects, we categorized each SZ subject as having either low MAP2-IR (SZ MAP2-IR(low)) or normal MAP2-IR (SZ MAP2-IR(normal)). Among SZ MAP-IR(low) subjects, mean DSD was significantly lower than in NPC subjects. However, mean DSD did not differ between SZ MAP2-IR(normal) and NPC subjects. Moreover, MAP2-IR statistically mediated small spine differences, with lower MAP2-IR values associated with fewer small spines. Our findings confirm that low density of small spines and low MAP2-IR are robust SZ phenotypes and suggest that MAP2-IR mediates the effect of SZ on DSD.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30795003      PMCID: PMC6461932          DOI: 10.1038/s41386-019-0350-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

Review 1.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 2.  Dendritic spine dynamics.

Authors:  D Harshad Bhatt; Shengxiang Zhang; Wen-Biao Gan
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

3.  NMDA receptor activation suppresses microtubule growth and spine entry.

Authors:  Lukas C Kapitein; Kah Wai Yau; Susana Montenegro Gouveia; Wouter A van der Zwan; Phebe S Wulf; Nanda Keijzer; Jeroen Demmers; Jacek Jaworski; Anna Akhmanova; Casper C Hoogenraad
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

4.  Post-translational modifications induce significant yet not extreme changes to protein structure.

Authors:  Fuxiao Xin; Predrag Radivojac
Journal:  Bioinformatics       Date:  2012-09-04       Impact factor: 6.937

Review 5.  Spine Dynamics: Are They All the Same?

Authors:  Kalen P Berry; Elly Nedivi
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

6.  Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system.

Authors:  F Capani; M H Ellisman; M E Martone
Journal:  Brain Res       Date:  2001-12-27       Impact factor: 3.252

7.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse.

Authors:  Ye Zhang; Steven A Sloan; Laura E Clarke; Christine Caneda; Colton A Plaza; Paul D Blumenthal; Hannes Vogel; Gary K Steinberg; Michael S B Edwards; Gordon Li; John A Duncan; Samuel H Cheshier; Lawrence M Shuer; Edward F Chang; Gerald A Grant; Melanie G Hayden Gephart; Ben A Barres
Journal:  Neuron       Date:  2015-12-10       Impact factor: 17.173

Review 8.  Why do patients with schizophrenia smoke?

Authors:  Georg Winterer
Journal:  Curr Opin Psychiatry       Date:  2010-03       Impact factor: 4.741

9.  DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia.

Authors:  B McKinney; Y Ding; D A Lewis; R A Sweet
Journal:  Transl Psychiatry       Date:  2017-02-14       Impact factor: 6.222

10.  MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction.

Authors:  Akihiro Harada; Junlin Teng; Yosuke Takei; Keiko Oguchi; Nobutaka Hirokawa
Journal:  J Cell Biol       Date:  2002-08-05       Impact factor: 10.539

View more
  12 in total

Review 1.  Spine dynamics in the brain, mental disorders and artificial neural networks.

Authors:  Haruo Kasai; Noam E Ziv; Hitoshi Okazaki; Sho Yagishita; Taro Toyoizumi
Journal:  Nat Rev Neurosci       Date:  2021-05-28       Impact factor: 34.870

2.  A Human-Specific Schizophrenia Risk Tandem Repeat Affects Alternative Splicing of a Human-Unique Isoform AS3MTd2d3 and Mushroom Dendritic Spine Density.

Authors:  Xin Cai; Zhi-Hui Yang; Hui-Juan Li; Xiao Xiao; Ming Li; Hong Chang
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

Review 3.  Unusual Molecular Regulation of Dorsolateral Prefrontal Cortex Layer III Synapses Increases Vulnerability to Genetic and Environmental Insults in Schizophrenia.

Authors:  Amy F T Arnsten; Elizabeth Woo; Shengtao Yang; Min Wang; Dibyadeep Datta
Journal:  Biol Psychiatry       Date:  2022-02-12       Impact factor: 12.810

4.  The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.

Authors:  Zhihui Yang; Danyang Zhou; Huijuan Li; Xin Cai; Weipeng Liu; Lu Wang; Hong Chang; Ming Li; Xiao Xiao
Journal:  Mol Psychiatry       Date:  2019-11-13       Impact factor: 15.992

Review 5.  Sleep and Memory Consolidation Dysfunction in Psychiatric Disorders: Evidence for the Involvement of Extracellular Matrix Molecules.

Authors:  Barbara Gisabella; Jobin Babu; Jake Valeri; Lindsay Rexrode; Harry Pantazopoulos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

6.  MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia.

Authors:  Rebecca DeGiosio; Ryan M Kelly; Adam M DeDionisio; Jason T Newman; Kenneth N Fish; Allan R Sampson; David A Lewis; Robert A Sweet
Journal:  NPJ Schizophr       Date:  2019-08-28

7.  A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development.

Authors:  Melanie J Grubisha; Tao Sun; Leanna Eisenman; Susan L Erickson; Shinnyi Chou; Cassandra D Helmer; Melody T Trudgen; Ying Ding; Gregg E Homanics; Peter Penzes; Zachary P Wills; Robert A Sweet
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 12.779

8.  Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.

Authors:  Chieh-Hsin Lin; Sheng Yang; Yu-Jhen Huang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

9.  MAP2 is differentially phosphorylated in schizophrenia, altering its function.

Authors:  M J Grubisha; X Sun; M L MacDonald; M Garver; Z Sun; K A Paris; D S Patel; R A DeGiosio; D A Lewis; N A Yates; C Camacho; G E Homanics; Y Ding; R A Sweet
Journal:  Mol Psychiatry       Date:  2021-02-01       Impact factor: 15.992

Review 10.  Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research.

Authors:  Melanie J Grubisha; Robert A Sweet; Matthew L MacDonald
Journal:  Front Mol Neurosci       Date:  2021-07-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.